Quarterly report · Q2

Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥2.9bn2023-06-01 → 2023-11-30StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Operating income¥115m2023-06-01 → 2023-11-30StandaloneOperating income
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Ordinary income¥110m2023-06-01 → 2023-11-30StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Profit before tax¥145m2023-06-01 → 2023-11-30StandaloneIncome before income taxes
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Net income¥93m2023-06-01 → 2023-11-30StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Total assets¥5.1bnat 2023-11-30StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2022-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-11-30StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.0bnat 2023-11-30StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2023-11-30StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-11-30StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31StandaloneCash and cash equivalents
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31dStandaloneCash and cash equivalents
Operating cash flow¥143m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥115m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥185m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥23.632023-06-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.852023-09-01 → 2023-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥23.162023-06-01 → 2023-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio38.9%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥55m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥28m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥198m
—segment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
—segment totalsegment profit2023-06-01 → 2023-11-30¥115m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2023-11-30¥115m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 517
ItemContextValueUnit
Gross profitCurrentYTDDuration_NonConsolidatedMember828266000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember224587000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember236759000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember50976000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember53823000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember51275000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember55925000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember7307000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember9482000JPY
Share based compensation expenses sgaPrior1YTDDuration_NonConsolidatedMember4251000JPY
Share based compensation expenses sgaCurrentYTDDuration_NonConsolidatedMember3350000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember330551000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember353608000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember668951000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember712951000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember225409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember115315000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember18000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember236000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember781000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember1996000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember-JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember675000JPY
Subsidy income noiPrior1YTDDuration_NonConsolidatedMember851000JPY
Subsidy income noiCurrentYTDDuration_NonConsolidatedMember-JPY
Insurance fee income noiPrior1YTDDuration_NonConsolidatedMember3565000JPY
Insurance fee income noiCurrentYTDDuration_NonConsolidatedMember-JPY
Other noiPrior1YTDDuration_NonConsolidatedMember1460000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember1331000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember6676000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember4239000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember8289000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember8655000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember15308000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember-JPY
Other noePrior1YTDDuration_NonConsolidatedMember577000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember812000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember24175000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember9467000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember207911000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember110087000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration_NonConsolidatedMember-JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration_NonConsolidatedMember1254000JPY
Gain on sales of investment securities eiPrior1YTDDuration_NonConsolidatedMember-JPY
Gain on sales of investment securities eiCurrentYTDDuration_NonConsolidatedMember998000JPY
Surrender value of insurance eiPrior1YTDDuration_NonConsolidatedMember-JPY
Surrender value of insurance eiCurrentYTDDuration_NonConsolidatedMember32949000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember-JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember35203000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2023-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2023-11-30pass